YD Bio Limited (YDESW)
NASDAQ: YDESW · Real-Time Price · USD · Warrants
0.608841
-0.0411 (-6.32%)
Apr 1, 2026, 1:54 PM EDT - Market open
Company Description
YD Bio Limited a biopharmaceutical company focuses on blood-based cancer detection and develops stem cell- and exosome-based therapeutics to transform the treatment of spectrum of diseases with unmet medical needs.
The company is based in Taipei, Taiwan.
Contact Details
Address: No. 3, Xingnan St., 12F. Taipei, 115001 Taiwan | |
| Website | ydesgroup.com |
Stock Details
| Ticker Symbol | YDESW |
| Exchange | NASDAQ |
| Stock Type | Warrants |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 2011674 |
| ISIN Number | KYG9835J1031 |
| SIC Code | 8071 |
Key Executives
| Name | Position |
|---|---|
| Ethan Shen | Chief Executive Officer |
| Edmund Hen | Chief Financial Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Feb 27, 2026 | 424B3 | Prospectus |
| Feb 26, 2026 | 6-K | Report of foreign issuer |
| Feb 17, 2026 | SCHEDULE 13G/A | Filing |
| Feb 5, 2026 | 424B3 | Prospectus |
| Jan 30, 2026 | 6-K | Report of foreign issuer |
| Jan 21, 2026 | 6-K | Report of foreign issuer |
| Jan 16, 2026 | 6-K | Report of foreign issuer |
| Jan 15, 2026 | 6-K | Report of foreign issuer |
| Jan 6, 2026 | 6-K | Report of foreign issuer |
| Jan 2, 2026 | S-8 | Securities to be offered to employees in employee benefit plans |